Skip to main content
SpringerLink
Log in

A Novel Approach to the Prevention of Atherosclerosis

  • Chapter
Molecular Autoimmunity

  • 480 Accesses

7. Conclusions

Studies in recent years have shown that the immune system plays a greater role in the pathogenesis of atherosclerosis than previously recognized. These findings open new possibilities of treatment or prevention of this disease, and approaches using antibodies are especially promising. Future studies should aim at further characterizing the fine specificities of beneficial antibodies and at optimizing the means of their delivery (active immunization versus passive administration).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Alderman, C.J.J., Bunyard, P.R., Chain, B.M., Foreman, J.C., Leake, D.S., and Katz, D.R. (2002). Effects of oxidized low density lipoprotein on dendritic cells: A possible immunoregulatory component of the atherogenic micro-environment? Cardiovasc. Res., 55, 806–819.

    Article  PubMed  CAS  Google Scholar 

  • Allen, S., Khan, S., Futwan, A.-M., Batten, P., and Yacoub, M. (1998). Native low density lipoprotein induced calcium transients trigger VCAM-1 and E selectin expression in cultured human vascular endothelial cells. J. Clin. Invest., 101, 1064–1075.

    PubMed  CAS  Google Scholar 

  • Ameli, S., Hultgardh-Nilsson, A., Regnstrom, J., Calara, F., Yano, J., Cercek, B., Shah, P.K., and Nilsson, J. (1996). Effect of immunization with homologous LDL and oxidized LDL on early atherosclerosis in hypercholesterolemic rabbits. Arterioscler. Thromb. Vasc. Biol., 16, 1074–1079.

    PubMed  CAS  Google Scholar 

  • Binder, C.J., Horkko, S., Dewan, A., Chang, M.K., Kieu, E.P., Goodyear, C.S., Shaw, P.X., Palinski, W., Witztum, J.L., and Silverman, G.J. (2003). Pneumococcal vaccination decreases atherosclerotic lesion formation: Molecular mimicry between Streptococcus pneumoniae and oxidized LDL. Nat. Med., 9, 736–743.

    PubMed  CAS  Google Scholar 

  • Boren, J., Olin, K., Lee, I., Chait, A., Wight, T.N., and Innerarity, T.L. (1998). Identification of the principal proteoglycan-binding site in LDL. J. Clin. Invest., 101, 2658–2664.

    PubMed  CAS  Google Scholar 

  • Breslow, J.L., Plump, A., and Dammerman, M. (1996). New mouse models of lipoprotein disorders and atherosclerosis. In V. Fuster, R. Ross, and E.J. Topol (eds) Atherosclerosis and Coronary Artery Disease. Lippincott-Raven, Philadelphia. pp. 363–378.

    Google Scholar 

  • Caligiuri, G., Nicoletti, A., Poirier, B., and Hansson, G.K. (2002). Protective immunity against atherosclerosis carried by B cells of hypercholesterolemic mice. J. Clin. Invest., 109, 745–753.

    Article  PubMed  CAS  Google Scholar 

  • Chang, M.K., Bergmark, C., Laurila, A., Horkko, S., Han, K.H., Friedman, P., Dennis, E.A., and Witztum, J.L. (1999). Monoclonal antibodies against oxidized low-density lipoprotein bind to apoptotic cells and inhibit their phagocytosis by elicited macrophages: Evidence that oxidation-specific epitopes mediate macrophage recognition. Proc. Natl. Acad. Sci. USA, 96, 6353–6358.

    PubMed  CAS  Google Scholar 

  • Cocca, B.A., Seal, S.N., DrsAgnillo, P., Mueller, Y.M., Katsikis, P.D., Rauch, J., Weigert, M., and Radic, M.Z. ((2001). Structural basis for autoantibody recognition of phosphatidylserine-beta 2 glycoprotein I and apoptotic cells. Proc. Natl. Acad. Sci. USA, 98, 13826–13831.

    Article  PubMed  CAS  Google Scholar 

  • Coutant, F., Agaugue, S., Perrin-Cocon, L., Andre, P., and Lotteau, V. (2004). Sensing environmental lipids by dendritic cell modulated its function. J. Immunol., 172, 54–60.

    PubMed  CAS  Google Scholar 

  • Dansky, H.M., Charlton, S.A., Harper, M.M., and Smith, J.D. (1997). T and B lymphocytes play a minor role in atherosclerotic plaque formation in the apolipoprotein E-deficient mouse. Proc. Natl. Acad. Sci. USA, 94, 4642–4646.

    Article  PubMed  CAS  Google Scholar 

  • Davenport, P.T. and Tipping, P.G. (2003). The role of interleukin-4 and interleukin-12 in the progression of atherosclerosis in apolipoprotein E-deficient mice. Am. J. Pathol., 163, 1117–1125.

    PubMed  CAS  Google Scholar 

  • Dong, M., Chapman, M., Brown, A.A., Frenette, P.S., Hynes, R.O., and Wagner, D.D. (1998). The combined role of P and E selectin in atherosclerosis. J. Clin. Invest., 102, 145–152.

    PubMed  CAS  Google Scholar 

  • Febbraio, M., Podrez, E.A., Smith, J.D., Hajjar, D.P., Hazen, S.L., Hoff, H.F., Sharma, K., and Silverstein, R.L. (2000). Targeted disruption of the class B scavenger receptor CD36 protects against atherosclerotic lesion development in mice. J. Clin. Invest., 105, 1049–1056.

    PubMed  CAS  Google Scholar 

  • Freigang, S., Horkko, S., Miller, E., Witztum, J.L., and Palinski, W. (1998). Immunization of LDL receptor-deficient mice with homologous malondialdehyde-modified and native LDL reduces progression of atherosclerosis by mechanisms other than induction of high titers of antibodies to oxidative neoepitopes. Arterioscler. Thromb. Vasc. Biol., 18, 1972–1982.

    PubMed  CAS  Google Scholar 

  • George, J., Afek, A., Gilburd, B., Levkovitz, H., Shaish, A., Goldberg, I., Kopolovic, Y., Wick, G., Shoenfeld, Y., and Harats, D. (1998). Hyperimmunization of apo-E-deficient mice with homologous malondialdehyde low-density lipoprotein suppresses early atherogenesis. Atherosclerosis, 138, 147–152.

    Article  PubMed  CAS  Google Scholar 

  • Glass, C.K. and Witztum, J.L. (2001). Atherosclerosis. The road ahead. Cell, 104, 503–516.

    Article  PubMed  CAS  Google Scholar 

  • Gupta, S., Pablo, A.M., Jiang, X.C, Wang, N., Tall, A.R., and Schindler, C. (1997). IFN-gamma potentiates atherosclerosis in ApoE knock-out mice. J. Clin. Invest., 99, 2752–2761.

    PubMed  CAS  Google Scholar 

  • Hansson, G.K. (1997). Cell-mediated immunity in atherosclerosis. Curr. Opin. Lipidol., 8, 301–311.

    PubMed  CAS  Google Scholar 

  • Hansson, G.K. (2001). Immune mechanisms in atherosclerosis. Arterioscler. Thromb. Vasc. Biol., 21, 1876–1890.

    PubMed  CAS  Google Scholar 

  • Haviv, Y.S. (2000). Association of anticardiolipin antibodies with vascular injury: Possible mechanisms. Postgrad. Med. J., 76, 625–628.

    Article  PubMed  CAS  Google Scholar 

  • Heinecke, J.W. (1997). Mechanisms of oxidative damage of low density lipoprotein in human atherosclerosis. Curr. Opin. Lipidol., 8, 268–274.

    PubMed  CAS  Google Scholar 

  • Horkko, S., Binder, C.J., Shaw, P.X., Chang, M.K., Silverman, G., Palinski, W., and Witztum, J.L. (2000). Immunological responses to oxidized LDL. Free Radic. Biol. Med., 28, 1771–1779.

    PubMed  CAS  Google Scholar 

  • Horkko, S., Miller, E., Branch, D.W., Palinski, W., and Witztum, J.L. (1997). The epitopes for some antiphospholipid antibodies are adducts of oxidized phospholipid and beta2 glycoprotein 1 (and other proteins). Proc. Natl. Acad. Sci. USA, 94, 10356–10361.

    Article  PubMed  CAS  Google Scholar 

  • Horkko, S., Olee, T., Mo, L., Branch, D.W., Woods, V.L.J., Palinski, W., Chen, P.P., and Witztum, J.L. (2001). Anticardiolipin antibodies from patients with the antiphospholipid antibody syndrome recognize epitopes in both beta(2)-glycoprotein 1 and oxidized low-density lipoprotein. Circulation, 103, 941–946.

    PubMed  CAS  Google Scholar 

  • Huang, J.T., Welch, J.S., Ricote, M., Binder, C.J., Willson, T.M., Kelly, C., Witztum, J.L., Funk, C.D., Conrad, D., and Glass, C.K. (1999). Interleukin-4-dependent production of PPAR-gamma ligands in macrophages by 12/15-lipoxygenase. Nature, 400, 378–382.

    PubMed  CAS  Google Scholar 

  • Hughes, G.R.V. (2000). Immunology, lupus and atheroma. Lupus, 9, 159–160.

    Article  PubMed  CAS  Google Scholar 

  • Kim, J.G., Keshava, C., Murphy, A.A., Pitas, R.E., and Parthasarathy, S. (1997). Fresh mouse peritoneal macrophages have low scavenger receptor activity. J. Lipid Res., 38, 2207–2215.

    PubMed  CAS  Google Scholar 

  • King, V.L., Szilvassy, S.J., and Daugherty, A. (2002). Interleukin-4 deficiency decreases atherosclerotic lesion formation in a site-specific manner in female LDL receptor-/-mice. Arterioscler. Thromb. Vasc. Biol., 22, 456–461.

    PubMed  CAS  Google Scholar 

  • Krieger, M. (1998). The best of cholesterols, the worst of cholesterols: A tale of two receptors. Proc. Natl. Acad. Sci. USA, 95, 4077–4080.

    Article  PubMed  CAS  Google Scholar 

  • Laman, J.D., de Smet, B.J.G.L., Schoneveld, A., and Meurs, M.V. (1997). CD40-CD40L interactions in atherosclerosis. Immunol. Today, 18, 272–277.

    Article  PubMed  CAS  Google Scholar 

  • Laurat, E., Poirier, B., Tupin, E., Caligiuri, G., Hansson, G.K., Bariety, J., and Nicoletti, A. (2001). In vivo downregulation of T helper cell 1 immune responses reduces atherogenesis in apolipoprotein E knockout mice. Circ. Res., 104, 197–202.

    CAS  Google Scholar 

  • Liao, F., Berliner, J.A., Mehrabian, M., Navab, M., Demer, L.L., Lusis, A.J., and Fogelman, A.M. (1991). Minimally modified low density lipoprotein is biologically active in vivo in mice. J. Clin. Invest., 87, 2253–2257.

    PubMed  CAS  Google Scholar 

  • Libby, P. (2000). Changing concepts of atherogenesis. J. Intern. Med., 247, 349–358.

    Article  PubMed  CAS  Google Scholar 

  • Libby, P. and Hansson, G.K. (1991). Biology of disease—Involvement of the immune system in human atherogenesis: Current knowledge and unanswered questions. Lab. Invest., 64, 5–15.

    PubMed  CAS  Google Scholar 

  • Ling, W., Lougheed, M., Suzuki, H., Buchan, A., Kodama, T., and Steinbrecher, U.P. (1997). Oxidized or acetylated low density lipoproteins are rapidly cleared by the liver in mice with disruption of the scavenger receptor class A type I/II gene. J. Clin. Invest., 100, 244–252.

    PubMed  CAS  Google Scholar 

  • Lopes-Virella, M.F., Binzafar, N., Rackley, S., Takei, A., La Via, M., and Virella, G. (1997). The uptake of LDL-IC by human macrophages: Predominant involvement of the FcγRI receptor. Atherosclerosis, 135, 161–170.

    Article  PubMed  CAS  Google Scholar 

  • Lusis, A.J. (2000). Atherosclerosis. Nature, 407, 233–241.

    Article  PubMed  CAS  Google Scholar 

  • Major, A.S., Fazio, S., and Linton, M.F. (2002). B lymphocyte deficiency increases atherosclerosis in LDL receptor null mice. Arterioscler. Thromb. Vasc. Biol., 22, 1892–1898.

    PubMed  CAS  Google Scholar 

  • Mallat, Z., Besnard, S., Duriez, M., Deleuze, V., Emmanuel, F., Bureau, M.F., Soubrier, F., Esposito, B., Duez, H., Fievet, C., Staels, B., Duverger, N., Scherman, D., and Tedgui, A. (1999). Protective role of interleukin-10 in atherosclerosis. Circ. Res., 85, e17–e24.

    PubMed  CAS  Google Scholar 

  • Matsuura, E., Kobayashi, K., Kasahara, J., Yasuda, T., and Makino, H. (2002). Anti-beta2 glycoprotein 1 autoantibodies and atherosclerosis. Int. Rev. Immunol., 21, 41–66.

    Google Scholar 

  • Mizutani, H., Kurata, Y., Kosugi, S., Shiraga, M., Kashiwagi, H., Tomiyama, Y., Kanakura, Y., Good, R.A., and Matsuzawa, Y. (1995). Monoclonal anticardiolipin autoantibodies established from the (New Zealand white × BXSB) F1 mouse model of antiphospholipid syndrome cross-react with oxidized low-density lipoprotein. Arthritis Rheum., 38, 1382–1388.

    PubMed  CAS  Google Scholar 

  • Monestier, M., Kandiah, D.A., Kouts, S., Novick, K.E., Ong, G.L., Radic, M.Z., and Krilis, S.A. (1996). Monoclonal antibodies from NZW × BXSB F1 mice to b2-glycoprotein I and cardiolipin. Species specificity and charge-dependent binding. J. Immunol., 156, 2631–2641.

    PubMed  CAS  Google Scholar 

  • Nicolo, D., Goldman, B.I., and Monestier, M. (2003). Passive administration of antiphospholipid antibody reduces atherosclerosis in LDLR-/-mice. Arthritis Rheum., 48, 2974–2978.

    Article  PubMed  CAS  Google Scholar 

  • Nicolo, D. and Monestier, M. (2004). Antiphospholipid antibodies and atherosclerosis. Clin. Immunol., 112, 183–189.

    Article  PubMed  CAS  Google Scholar 

  • Palinski, W., Horkko, S., Miller, E., Steinbrecher, U.P., Powell, H.C., Curtiss, L.K., and Witztum, J. L. (1996). Cloning of monoclonal autoantibodies to epitopes of oxidized lipoproteins from apolipoprotein E-deficient mice. Demonstration of epitopes of oxidized low density lipoprotein in human plasma. J. Clin. Invest., 98, 800–814.

    PubMed  CAS  Google Scholar 

  • Palinski, W., Miller, E., and Witztum, J.L. (1995a). Immunization of low density lipoprotein (LDL) receptor-deficient rabbits with homologous malondialdehyde-modified LDL reduces atherogenesis. Proc. Natl. Acad. Sci. USA, 92, 821–825.

    PubMed  CAS  Google Scholar 

  • Palinski, W., Tangirala, R.K., Miller, E., Young, S.G., and Witztum, J.L. (1995b). Increased autoantibody titers against epitopes of oxidized LDL in LDL receptor-deficient mice with increased atherosclerosis. Arterioscler. Thromb. Vasc. Biol., 15, 1569–1576.

    PubMed  CAS  Google Scholar 

  • Palinski, W. and Witztum, J.L. (2000). Immune responses to oxidative neoepitopes on LDL and phospholipids modulate the development of atherosclerosis. J. Intern. Med., 247, 371–380.

    Article  PubMed  CAS  Google Scholar 

  • Palinski, W., Yla-Herttuala, S., Rosenfeld, M.E., Butler, S.W., Socher, S.A., Parthasarathy, S., Curtiss, L.K., and Witztum, J.L. (1990). Antisera and monoclonal antibodies specific for epitopes generated during oxidative modification of low density lipoprotein. Arteriosclerosis, 10, 325–335.

    PubMed  CAS  Google Scholar 

  • Perrin-Cocon, L., Coutant, F., Agaugue, S., Deforges, S., Andre, P., and Lotteau, V. (2001). Oxidized low-density lipoprotein promotes mature dendritic cell transition from differentiating monocyte. J. Immunol., 167, 3785–3791.

    PubMed  CAS  Google Scholar 

  • Pinderski, L.J., Fischbein, M.P., Subbanagounder, G., Fishbein, M.C., Kubo, N., Cheroutre, H., Curtiss, L.K., Berliner, J.A., and Boisvert, W.A. (2002). Overexpression of interleukin10 by activated T lymphocytes inhibits atherosclerosis in LDL receptor deficient mice by altering lymphocyte and macrophage phenotype. Circ. Res., 90, 1064–1071.

    Article  PubMed  CAS  Google Scholar 

  • Rader, D.J. and FitzGerald, G.A. (1998). State of the art: Atherosclerosis in a limited edition. Nat. Med., 4, 899–900.

    Article  PubMed  CAS  Google Scholar 

  • Rajavashisth, T., Qiao, J., Tripathi, S., Tripathi, J., Mishra, N., Hua, M., Wang, X.P., Loussararian, A., Clinton, S., Libby, P., and Lusis A.J. (1998). Heterozygous osteopetrotic(op) mutation reduces atherosclerosis in LDL receptor deficient mice. J. Clin. Invest., 101, 2702–2710.

    PubMed  CAS  Google Scholar 

  • Reddel, S.W., Wang, Y.X., Sheng, Y.H., and Krilis, S.A. (2000). Epitope studies with anti-beta 2-glycoprotein I antibodies from autoantibody and immunized sources. J. Autoimmun., 15, 91–96.

    Article  PubMed  CAS  Google Scholar 

  • Romero, F.I., Khamashta, M.A., and Hughes, G.R.V. (2000). Lipoprotein(a) oxidation and autoantibodies; a new path in atherothrombosis. Lupus, 9, 206–209.

    Article  PubMed  CAS  Google Scholar 

  • Rose, N. and Afanasyeva, M. (2003). Autoimmunity: Busting the atherosclerotic plaque. Nat. Med., 9, 641–642.

    Article  PubMed  CAS  Google Scholar 

  • Roselaar, S.E., Kakkanathu, P.X., and Daugherty, A. (1996). Lymphocyte populations in atherosclerotic lesions of apoE-/-and LDL receptor-/-mice. Decreasing density with disease progression. Arterioscler. Thromb. Vasc. Biol., 16, 1013–1018.

    PubMed  CAS  Google Scholar 

  • Ross, R. (1995). Cell biology of atherosclerosis. Annu. Rev. Physiol., 57, 791–804.

    Article  PubMed  CAS  Google Scholar 

  • Roubey, R.A.S. (1996). Immunology of the antiphospholipid antibody syndrome. Arthritis Rheum., 39, 1444–1454.

    PubMed  CAS  Google Scholar 

  • Sanan, D.A., Newland, D.L., Tao, R., Marcovina, S., Wang, J., Mooser, V., Hammer, R.E., and Hobbs, H.H. (1998). Low density lipoprotein receptor-negative mice expressing human apolipoprotein B-100 develop complex atherosclerotic lesions on a chow diet: No accentuation by apolipoprotein(a). Proc. Natl. Acad. Sci. USA, 95, 4544–4549.

    Article  PubMed  CAS  Google Scholar 

  • Sata, M. and Walsh, K. (1998). Oxidized LDL activates fas-mediated endothelial cell apoptosis. J. Clin. Invest., 102, 1682–1689.

    PubMed  CAS  Google Scholar 

  • Shaw, P.X., Goodyear, C.S., Chang, M.K., Witztum, J.L., and Silverman, G.J. (2003). The autoreactivity of antiphosphorylcholine antibodies for atherosclerosis associated neo-antigens and apoptotic cells. J. Immunol., 170, 6151–6157.

    PubMed  CAS  Google Scholar 

  • Shaw, P.X., Horkko, S., Chang, M.K., Curtiss, L.K., Palinski, W., Silverman, G.J., and Witztum, J.L. (2000). Natural antibodies with the T15 idiotype may act in atherosclerosis, apoptotic clearance, and protective immunity. J. Clin. Invest., 105, 1731–1740.

    PubMed  CAS  Google Scholar 

  • Shih, P.T., Elices, M.J., Fang, Z.T., Ugarova, T.P., Strahl, D., Territo, M.C., Frank, J.S., Kovach, N.L., Cabanas, C., Berliner, J.A., and Vora, D.K. (1999). Minimally modified low density lipoprotein induces monocyte adhesion to endothelial connecting segment-1 by activating alpha1 integrin. J. Clin. Invest., 103, 613–625.

    PubMed  CAS  Google Scholar 

  • Skalen, K., Gustaffson, M., Rydberg, E.K., Hulten, L.M., Wiklund, O., Innerarity, T.L., and Boren, J. (2002). Subendothelial retention of atherogenic lipoproteins in early atherosclerosis. Nature, 417, 750–754.

    PubMed  CAS  Google Scholar 

  • Song, L., Leung, C., and Schindler, C. (2001). Lymphocytes are important in early atherosclerosis. J. Clin. Invest., 108, 251–259.

    Article  PubMed  CAS  Google Scholar 

  • Steinberg, D. (1991). Antioxidants and atherosclerosis. A current assessment. Circulation, 84, 1420–1425.

    PubMed  CAS  Google Scholar 

  • Steinberg, D. (1996). Oxidized low density lipoprotein — An extreme example of lipoprotein heterogeneity. Isr. J. Med. Sci., 32, 469–472.

    PubMed  CAS  Google Scholar 

  • Terpstra, V., Kondratenko, N., and Steinberg, D. (1997). Macrophages lacking scavenger receptor A show a decrease in binding and uptake of acetylated low-density lipoprotein and of apoptotic thymocytes, but not of oxidatively damaged red blood cells. Proc. Natl. Acad. Sci. USA, 94, 8127–8131.

    Article  PubMed  CAS  Google Scholar 

  • Thiagarajan, P. (2001). Atherosclerosis, autoimmunity, and systemic lupus erythematosus. Circulation, 104, 1876–1877.

    PubMed  CAS  Google Scholar 

  • Urowitz, M.B. and Gladman, D.D. (2000). Accelerated atheroma in lupus-background. Lupus, 9, 161–165.

    Article  PubMed  CAS  Google Scholar 

  • Vaarala, O. (2000). Autoantibodies to modified LDLs and other phospholipid-protein complexes as markers of cardiovascular diseases. J. Intern. Med., 247, 381–384.

    Article  PubMed  CAS  Google Scholar 

  • Varadhachary, A.S., Monestier, M., and Salgame, P. (2001). Reciprocal induction of IL-10 and IL-12 from macrophages by low density lipoproteins and its oxidized forms. Cell. Immunol., 213, 45–51.

    Article  PubMed  CAS  Google Scholar 

  • Wick, G., Schett, G., Amberger, A., Kleindienst, R., and Xu, Q. (1995). Is atherosclerosis an immunologically mediated disease? Immunol. Today, 16, 27–33.

    Article  PubMed  CAS  Google Scholar 

  • Zhou, X., Caligiuri, G., Hamsten, A., Lefvert, A.K., and Hansson, G.K. (2001). LDL immunization induces T-cell-dependent antibody formation and protection against atherosclerosis. Arterioscler. Thromb. Vasc. Biol., 21, 108–114.

    PubMed  CAS  Google Scholar 

  • Zibara, K., Malaud, E., and McGregor, J.L. (2002). CD36 mRNA and protein expression levels are significantly increased in the heart and testis of apoE deficient mice in comparison to wild type(C57BL/6). J. Biomed. Biotechnol., 2, 14–21.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Microbiology and Immunology, Temple University School of Medicine, Philadelphia, Pennsylvania, 19140

    Sun-Ah Kang & Marc Monestier

Authors
  1. Sun-Ah Kang
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Marc Monestier
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Institut National de Santé et de Recherche Médicale (INSERM), Paris, France

    Moncef Zouali

Rights and permissions

Reprints and permissions

Copyright information

© 2005 Springer Science+Business Media, Inc.

About this chapter

Cite this chapter

Kang, SA., Monestier, M. (2005). A Novel Approach to the Prevention of Atherosclerosis. In: Zouali, M. (eds) Molecular Autoimmunity. Springer, Boston, MA. https://doi.org/10.1007/0-387-24534-0_27

Download citation

Publish with us

Policies and ethics

Search

Navigation